These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 32550700)

  • 1. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
    Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
    Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK/NF-κB/NLRP3 pathway.
    Zhang K; Lin G; Nie Z; Jin S; Bing X; Li Z; Li M
    Mol Cell Biochem; 2024 Aug; 479(8):2069-2079. PubMed ID: 37566200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
    Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
    Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C.
    Liao M; Peng L
    Cell Mol Biol Lett; 2020; 25():22. PubMed ID: 32206066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
    Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.
    Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H
    Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
    Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
    J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway.
    Fu XY; Zhou WB; Xu J
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1829-1840. PubMed ID: 32141552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
    Wang M; Wang W; Ding J; Wang J; Zhang J
    Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
    Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity.
    Song P; Song B; Liu J; Wang X; Nan X; Wang J
    Clin Transl Oncol; 2021 Apr; 23(4):892-901. PubMed ID: 32974862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.